文献速递先天性心脏病外科瓣膜外科

主动脉瓣闭锁:外科姑息与一期移植的长期结局

Surgical palliation or primary transplantation for aortic valve atresia.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-09-25

该研究纳入1994至2000年26家先天性心脏病外科医师学会医院收治的565例主动脉瓣闭锁新生儿,初始治疗为外科姑息(453例)或一期心脏移植(68例),随访至青春期。

要点

  • 供体有限,仅对姑息后生存极差的高危新生儿考虑一期移植。

核心结论

  • 1994至2000年队列中,一期心脏移植治疗主动脉瓣闭锁的生存优于初始外科姑息,症状更少且生活质量相当。
  • 鉴于新生儿和婴儿供心有限,可对预测姑息后生存极差的高危新生儿考虑一期移植。

研究设计与样本

  • 研究为1994至2000年26家先天性心脏病外科医师学会医院收治的565例主动脉瓣闭锁新生儿的起始队列,每年随访生存状态。
  • 初始治疗包括外科姑息(n=453)和一期心脏移植(n=68)。
  • 向既往随访存活的部分患者(n=198)横断面发放PedsQL健康相关生活质量问卷,回收80份。

主要发现

  • 二次移植后生存(9年48%)低于一期移植(74%)。

临床怎么用

  • 对主动脉瓣闭锁新生儿,在供心可用时可考虑一期心脏移植以改善长期生存。
  • 对预测外科姑息后生存极差的高危新生儿,可优先评估一期移植。
  • 需向家庭说明姑息治疗后症状负担可能更高。

局限性

  • 生活质量分析为横断面设计,仅80例回复问卷。
  • 研究队列为1994至2000年,距今较久,可能不反映当前诊疗水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to describe the surgical pathway progression through adolescence of an inception cohort of neonates with aortic valve atresia managed initially with surgical palliation or primary transplantation, comparing survival and self-reported health-related quality of life. METHODS: From 1994 to 2000, 565 neonates with aortic atresia were admitted to 26 Congenital Heart Surgeons' Society hospitals and followed annually for vital status. Initial management included surgical palliation (n = 453) and primary cardiac transplantation (n = 68). PedsQL health-related quality of life questionnaires were sent cross-sectionally to a subgroup of 198 patients alive at previous follow-up, with 80 responses. RESULTS: Risk of death was initially high for both treatment strategies. However, compared with initial surgical palliation, survival with primary transplantation, including wait-list mortality, was greater and persisted long-term (65% vs 40% at 15 years; P = .002). Survival after secondary transplantation (48% at 9 years) was lower than after primary transplantation (74%). Health-related quality of life total score was lower overall than that of the general adolescent population (71 ± 16 vs 84 ± 13; P = .0001; normal = 100), but similar to that of adolescents with chronic diseases. It was similar in the surgical palliation and primary transplantation groups (70 ± 16 vs 75 ± 15; P = .3). Patients who received surgical palliation reported more symptoms (76 ± 15 vs 63 ± 18; P = .02). CONCLUSIONS: Patients receiving primary heart transplantation for aortic atresia in 1994 to 2000 experienced better survival, fewer symptoms, and equivalent quality of life compared with those undergoing initial surgical palliation. Notwithstanding the limited availability of neonatal and infant donor hearts, primary transplantation may be considered for those neonates with risk factors predictive of exceptionally poor survival after surgical palliation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Stackhouse KA, McCrindle BW, Blackstone EH, et al. Surgical palliation or primary transplantation for aortic valve atresia. J Thorac Cardiovasc Surg. 2019. PMID: 31740116. doi:10.1016/j.jtcvs.2019.08.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。